However, further experiments where our protocol of chronic insulin stimulation is complemented with other factors known to exacerbate insulin resistance in T2D patients, such as fatty acids, corticosteroids and pro-inflammatory cytokines, would be required to potentially further enhance an established condition of insulin resistance as it physiologically happens in humans. The gene discussed is INS; the disease is type 2 diabetes mellitus.